Skip to content
GenoLensGenoLens

LSS

Chr 21q22.3

lanosterol synthase

Aliases:
OSC
MANE:
ENST00000397728.8

Annotations refreshed 11 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bilateral congenital or childhood onset cataracts

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Non-syndromic hypotrichosis

    BIALLELIC, autosomal or pseudoautosomal
  • Ectodermal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Ichthyosis and erythrokeratoderma

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Alopecia-intellectual disability syndrome

    0.77
  • Total congenital cataract

    0.71
  • cataract 44

    0.68
  • hypotrichosis 14

    0.63
  • hypotrichosis

    0.60
  • neurodegenerative disease

    0.54
  • early-onset non-syndromic cataract

    0.49
  • hereditary disease

    0.45
  • cataract

    0.39
  • autosomal recessive palmoplantar keratoderma and congenital alopecia

    0.38

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Lanosterol synthase

Key enzyme in the cholesterol biosynthesis pathway. Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus (PubMed:14766201, PubMed:26200341, PubMed:7639730). Through the production of lanosterol may regulate lens protein aggregation and increase transparency (PubMed:26200341)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.